 |
patisiran |
|---|---|
| Trade Name | |
| Orphan Indication | Amyloidosis |
| USA Market Approval | USA |
| USA Designation Date | 2012-06-07 00:00:00 |
| Sponsor | Alnylam Pharmaceuticals, Inc.;300 Third Street;Cambridge, Maryland, 02142 |
| |
patisiran |
|---|---|
| Trade Name | |
| Orphan Indication | Amyloidosis |
| USA Market Approval | USA |
| USA Designation Date | 2012-06-07 00:00:00 |
| Sponsor | Alnylam Pharmaceuticals, Inc.;300 Third Street;Cambridge, Maryland, 02142 |